He et al. demonstrated for the first time that FOXO1 exists in autophagy regulation and can cause oxidative stress in human CCA cells by impairing autophagy flux, suggesting that FOXO1 may be a potential therapeutic target for CCA [79]. This evidence concerns the gene FOXO1 and cholangiocarcinoma.